Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dronabinol"'
Autor:
Roepke S; Department of Psychiatry and Neurosciences, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany. Stefan.roepke@charite.de.; Oberberg Fachkliniken for Psychiatry, Psychosomatics and Psychotherapy, Berlin and Brandenburg, Germany. Stefan.roepke@charite.de., Schoofs N; Department of Psychiatry and Neuroscience, Charité Universitätsmedizin Berlin, Charité Campus Mitte, Berlin, Germany., Priebe K; Department of Psychiatry and Neuroscience, Charité Universitätsmedizin Berlin, Charité Campus Mitte, Berlin, Germany., Wülfing F; Department of Psychiatry and Neuroscience, Charité Universitätsmedizin Berlin, Charité Campus Mitte, Berlin, Germany., Schmahl C; Department of Psychosomatic Medicine and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany., Röhle R; Charité - Universitätsmedizin Berlin, Institute of Biometry and Clinical Epidemiology, Berlin, Germany., Zähringer J; Department of Psychosomatic Medicine and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany., Lotter T; Department of Psychosomatic Medicine and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.; Department of Psychosomatic Medicine and Psychotherapy, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Otte C; Department of Psychiatry and Neurosciences, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany., Koglin S; Department of Psychiatry and Neurosciences, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany.
Publikováno v:
BMC psychiatry [BMC Psychiatry] 2023 May 05; Vol. 23 (1), pp. 319. Date of Electronic Publication: 2023 May 05.
Autor:
Raymundi AM; Department of Pharmacology, Federal University of Parana, Curitiba, PR, Brazil., da Silva TR; Department of Pharmacology, Federal University of Parana, Curitiba, PR, Brazil., Sohn JMB; Department of Pharmacology, Federal University of Parana, Curitiba, PR, Brazil., Bertoglio LJ; Department of Pharmacology, Federal University of Santa Catarina, Florianopolis, SC, Brazil., Stern CA; Department of Pharmacology, Federal University of Parana, Curitiba, PR, Brazil. cristinastern.cs@gmail.com.
Publikováno v:
BMC psychiatry [BMC Psychiatry] 2020 Aug 26; Vol. 20 (1), pp. 420. Date of Electronic Publication: 2020 Aug 26.
Autor:
Favrat B; Unité de Médecine du Trafic, Institut Universitaire de Médecine Légale, 1005 Lausanne, Switzerland. bernard.favrat@hospvd.ch, Ménétrey A, Augsburger M, Rothuizen LE, Appenzeller M, Buclin T, Pin M, Mangin P, Giroud C
Publikováno v:
BMC psychiatry [BMC Psychiatry] 2005 Apr 01; Vol. 5, pp. 17. Date of Electronic Publication: 2005 Apr 01.
Autor:
Bhardwaj AK; Discipline of Addiction Medicine, Central Clinical School, University of Sydney, Sydney, NSW, Australia. anjali.bhardwaj@sydney.edu.au.; The Langton Centre, Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, NSW, Australia. anjali.bhardwaj@sydney.edu.au.; School of Psychology, University of Sydney, Sydney, NSW, Australia. anjali.bhardwaj@sydney.edu.au., Allsop DJ; School of Psychology, University of Sydney, Sydney, NSW, Australia., Copeland J; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia., McGregor IS; School of Psychology, University of Sydney, Sydney, NSW, Australia., Dunlop A; Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW, Australia., Shanahan M; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia., Bruno R; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.; School of Medicine, University of Tasmania, Hobart, TAS, Australia., Phung N; Centre for Addiction Medicine, Cumberland Hospital, Western Sydney Local Health District, Sydney, NSW, Australia., Montebello M; The Langton Centre, Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, NSW, Australia., Sadler C; Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW, Australia., Gugusheff J; Discipline of Addiction Medicine, Central Clinical School, University of Sydney, Sydney, NSW, Australia.; The Langton Centre, Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, NSW, Australia., Jackson M; Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW, Australia., Luksza J; Centre for Addiction Medicine, Cumberland Hospital, Western Sydney Local Health District, Sydney, NSW, Australia., Lintzeris N; Discipline of Addiction Medicine, Central Clinical School, University of Sydney, Sydney, NSW, Australia.; The Langton Centre, Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, NSW, Australia.
Publikováno v:
BMC psychiatry [BMC Psychiatry] 2018 May 18; Vol. 18 (1), pp. 140. Date of Electronic Publication: 2018 May 18.
Autor:
Stefan Roepke, Nikola Schoofs, Kathlen Priebe, Felix Wülfing, Christian Schmahl, Robert Röhle, Jenny Zähringer, Tobias Lotter, Christian Otte, Stefanie Koglin
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Distressing nightmares are a core symptom of posttraumatic stress disorder (PTSD) and contribute to psychiatric comorbidity, impaired physical health and decreased social functioning. No specific pharmacological treatment for PTSD
Externí odkaz:
https://doaj.org/article/3aa332bb967b44c5a23d6bdd0f283605
Autor:
Jeferson Machado Batista Sohn, Ana Maria Raymundi, Thiago R. da Silva, Cristina A.J. Stern, Leandro J. Bertoglio
Publikováno v:
BMC Psychiatry, Vol 20, Iss 1, Pp 1-17 (2020)
BMC Psychiatry
BMC Psychiatry
Background Posttraumatic stress disorder (PTSD) may stem from the formation of aberrant and enduring aversive memories. Some PTSD patients have recreationally used Cannabis, probably aiming at relieving their symptomatology. However, it is still larg
Autor:
David J. Allsop, Melissa A Jackson, Nicholas Lintzeris, Adrian Dunlop, Jan Copeland, Mark Montebello, Nghi Phung, Jessica Gugusheff, Marian Shanahan, Raimondo Bruno, Jennifer Luksza, Anjali K. Bhardwaj, Iain S. McGregor, Craig Sadler
Publikováno v:
BMC Psychiatry, Vol 18, Iss 1, Pp 1-14 (2018)
BMC Psychiatry
BMC Psychiatry
Background The cannabis extract nabiximols (Sativex®) effectively supresses withdrawal symptoms and cravings in treatment resistant cannabis dependent individuals, who have high relapse rates following conventional withdrawal treatments. This study
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.